StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)

Close on Nov 17, 2026Market cap $82.56BP/E –Yield –

Moderna cash

Cash and short-term investments held at the end of each period.

Moderna's cash was $5.14B at Jun 30, 2026. For fiscal 2025 it was $5.80B, down 17.5% from the year before. Over ten years it grew 43.3% a year on average. The highest annual figure on record is $10.74B in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.80B-17.5%
FY2024Dec 31, 2024$7.03B-18.3%
FY2023Dec 31, 2023$8.60B-13.2%
FY2022Dec 31, 2022$9.91B-7.7%
FY2021Dec 31, 2021$10.74B+132.4%
FY2020Dec 31, 2020$4.62B+314.3%
FY2019Dec 31, 2019$1.12B-27.3%
FY2018Dec 31, 2018$1.53B+99.4%
FY2017Dec 31, 2017$768.78M+1148.8%
FY2016Dec 31, 2016$61.56M-61.3%
FY2015Dec 31, 2015$159.04M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.14B+0.1%
Q1 FY2026Mar 31, 2026$5.21B-12.9%
Q4 FY2025Dec 31, 2025$5.80B-17.5%
Q3 FY2025Sep 30, 2025$4.50B-34.4%
Q2 FY2025Jun 30, 2025$5.13B-39.5%
Q1 FY2025Mar 31, 2025$5.98B-29.9%
Q4 FY2024Dec 31, 2024$7.03B-18.3%
Q3 FY2024Sep 30, 2024$6.87B-9.3%
Q2 FY2024Jun 30, 2024$8.49B+0.3%
Q1 FY2024Mar 31, 2024$8.52B-4.5%
Q4 FY2023Dec 31, 2023$8.60B-13.2%
Q3 FY2023Sep 30, 2023$7.57B-9.3%
Q2 FY2023Jun 30, 2023$8.46B+7.1%
Q1 FY2023Mar 31, 2023$8.92B-11.8%
Q4 FY2022Dec 31, 2022$9.91B-7.7%
Q3 FY2022Sep 30, 2022$8.35B-6.3%
Q2 FY2022Jun 30, 2022$7.90B-1.2%
Q1 FY2022Mar 31, 2022$10.12B+30.8%
Q4 FY2021Dec 31, 2021$10.74B+132.4%
Q3 FY2021Sep 30, 2021$8.91B+171.8%
Q2 FY2021Jun 30, 2021$7.99B+194.0%
Q1 FY2021Mar 31, 2021$7.74B+535.1%
Q4 FY2020Dec 31, 2020$4.62B+314.3%
Q3 FY2020Sep 30, 2020$3.28B+209.6%
Q2 FY2020Jun 30, 2020$2.72B+153.9%
Q1 FY2020Mar 31, 2020$1.22B+9.8%
Q4 FY2019Dec 31, 2019$1.12B-27.3%
Q3 FY2019Sep 30, 2019$1.06B+533.6%
Q2 FY2019Jun 30, 2019$1.07B+661.2%
Q1 FY2019Mar 31, 2019$1.11B+1125.6%
Q4 FY2018Dec 31, 2018$1.53B+99.4%
Q3 FY2018Sep 30, 2018$167.06M+171.4%
Q2 FY2018Jun 30, 2018$140.62M-11.6%
Q1 FY2018Mar 31, 2018$90.48M–
Q4 FY2017Dec 31, 2017$768.78M–
Q4 FY2016Dec 31, 2016$61.56M–
Q4 FY2015Dec 31, 2015$159.04M–

More Moderna figures

See a number that looks wrong?